English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
IR780/Gemcitabine-conjugated metal-phenolic network enhanced photodynamic cancer therapy Journal article
Zhou, Songtao, Tian, Hao, Yan, Jie, Zhang, Zhan, Wang, Guohao, Yu, Xinying, Sang, Wei, Li, Bei, Mok, Greta S.P., Song, Jie, Dai, Yunlu. IR780/Gemcitabine-conjugated metal-phenolic network enhanced photodynamic cancer therapy[J]. Chinese Chemical Letters, 2024, 35(1), 108312.
Authors:  Zhou, Songtao;  Tian, Hao;  Yan, Jie;  Zhang, Zhan;  Wang, Guohao; et al.
Favorite | TC[WOS]:10 TC[Scopus]:7  IF:9.4/7.3 | Submit date：2024/02/22
Metal Phenolic Network  Ir780  Photodynamic Therapy  Breast Cancer  Gemcitabine  
Nardoguaianone L Isolated from Nardostachys jatamansi Improved the Effect of Gemcitabine Chemotherapy via Regulating AGE Signaling Pathway in SW1990 Cells Journal article
Zheng, Yi Dan, Ma, Li Mei, Lu, Jin Jian, Chai, Tian, Naghavi, Mohammad Reza, Ma, Jun Yi, Sang, Chun Yan, Yang, Jun Li. Nardoguaianone L Isolated from Nardostachys jatamansi Improved the Effect of Gemcitabine Chemotherapy via Regulating AGE Signaling Pathway in SW1990 Cells[J]. Molecules, 2022, 27(20), 6849.
Authors:  Zheng, Yi Dan;  Ma, Li Mei;  Lu, Jin Jian;  Chai, Tian;  Naghavi, Mohammad Reza; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.2/4.6 | Submit date：2022/11/07
Age-rage Signaling Pathway  Gemcitabine  Pancreatic Cancer  Proteomic  Sw1990 Cells  
c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer Journal article
Yao, Jingjing, Huang, Min, Shen, Qinghong, Ding, Ming, Yu, Shaofang, Guo, Yajuan, Lin, Yuefang, Zheng, Yaqiu, Chen, Wenbo, Yan, Wenxin, Liu, Zhongqiu, Wang, Dawei, Hu, Ming, Lu, Linlin. c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Yao, Jingjing;  Huang, Min;  Shen, Qinghong;  Ding, Ming;  Yu, Shaofang; et al.
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:4.4/5.0 | Submit date：2023/01/30
Artesunate  C-myc  Gemcitabine Resistance  Pancreatic Cancer  Pd-l1  
A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response Journal article
Zhang K., Kim C., Wu X., Loera S., Wang Y., Chu P., Lim D., Shibata S., Yen Y.. A phase II study of hydroxyurea combined with gemcitabine in patients with head and neck squamous carcinoma and gene expression profiles correlated to poor response[J]. Head and Neck Oncology, 2013, 5(3).
Authors:  Zhang K.;  Kim C.;  Wu X.;  Loera S.;  Wang Y.; et al.
Favorite |  | Submit date：2019/01/16
Gene expression profile  Head and neck squamous cell carcinoma (HNSCC)  Hydroxyurea and gemcitabine